Advertisement

Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib

Matthias Mayerhofer, Karoline V. Gleixner, Julia Mayerhofer, Gregor Hoermann, Eva Jaeger, Karl J. Aichberger, Rene G. Ott, Khaled Greish, Hideaki Nakamura, Sophia Derdak, Puchit Samorapoompichit, Winfried F. Pickl, Veronika Sexl, Harald Esterbauer, Ilse Schwarzinger, Christian Sillaber, Hiroshi Maeda and Peter Valent

Article Information

Citation 
vol. 111 no. 4 2200-2210
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted November 2, 2006
  • Accepted November 5, 2007
  • Published online February 8, 2008.

Article Versions


Contributors 
  • Matthias Mayerhofer, 1Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria; 2Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria;
  • Karoline V. Gleixner, 1Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria;
  • Julia Mayerhofer, 1Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria;
  • Gregor Hoermann, 1Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria; 2Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria;
  • Eva Jaeger, 2Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria;
  • Karl J. Aichberger, 1Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria;
  • Rene G. Ott, 4Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;
  • Khaled Greish, 4Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;
  • Hideaki Nakamura, 4Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;
  • Sophia Derdak, 5Institute of Immunology, Medical University of Vienna, Vienna, Austria; and
  • Puchit Samorapoompichit, 6Institute of Histology and Embryology, Medical University of Vienna, Vienna, Austria
  • Winfried F. Pickl, 5Institute of Immunology, Medical University of Vienna, Vienna, Austria; and
  • Veronika Sexl, 3Department of Pharmacology, Medical University of Vienna, Vienna, Austria;
  • Harald Esterbauer, 2Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria;
  • Ilse Schwarzinger, 2Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Vienna, Vienna, Austria;
  • Christian Sillaber, 1Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria;
  • Hiroshi Maeda, 4Department of Microbiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan;
  • Peter Valent, 1Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output